Munich, Germany

Anette-G Ziegler

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technische Universitát Dresden. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anette-G Ziegler. Retrieved from https://idiyas.com/inventor/anette-g-ziegler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anette-G Ziegler: Innovator in Diabetes Research

Introduction

Anette-G Ziegler is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of diabetes research, particularly in understanding the risk factors associated with Type 1 diabetes. His innovative work has led to the development of a patented method that aims to determine the risk of developing this chronic condition.

Latest Patents

Anette-G Ziegler holds a patent for a "Method for Determining the Risk to Develop Type 1 Diabetes." This patent represents a crucial advancement in the early identification of individuals at risk, potentially leading to better preventive measures and treatments.

Career Highlights

Throughout his career, Ziegler has worked with esteemed institutions such as Technische Universität Dresden and Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Anette-G Ziegler has collaborated with notable colleagues, including Ezio Bonifacio and Fabian Theis. These partnerships have enriched his research and expanded the impact of his findings in the scientific community.

Conclusion

Anette-G Ziegler's innovative contributions to diabetes research highlight his role as a key figure in the scientific community. His patented method for assessing the risk of Type 1 diabetes is a testament to his dedication to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…